» Articles » PMID: 12182445

Effect of in Vivo GnRH Agonist and GnRH Antagonist on HCG and Insulin-stimulated Progesterone Production by Human Granulosa-lutein Cells in Vitro

Overview
Publisher Springer
Date 2002 Aug 17
PMID 12182445
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate hCG and insulin-stimulated progesterone (P) production by human granulosa-lutein cells (hGLC) in vitro.

Methods: hGLCs were isolated from patients undergoing IVF-ET cycles in which GnRH agonist or GnRH antagonist was used to prevent a midcycle gonadotropin surge. The cells were cultured for 3 days, and then treated with hCG 0.5, 1, and 10 IU/I, and insulin 0.01, 0.1, and 1 microM in serum free conditions. In vitro P production was measured by enzyme immunoassay.

Results: hCG stimulated P production by hGLCs from cycles in which GnRH antagonist was used, but a blunted response was seen in GnRH-agonist treated cycles. Insulin-stimulated P production was similar in cells from cycles in which GnRH-agonist or GnRH-antagonist treatment was used.

Conclusions: Because insulin and hCG may share common pathways beyond the level of receptor activation, we hypothesize that GnRH agonist, but not GnRH antagonist, may affect the expression and/or activation of LH receptors in the hGLCs.

Citing Articles

The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Mitwally M, Casper R, Diamond M Reprod Biol Endocrinol. 2005; 3:54.

PMID: 16202169 PMC: 1266397. DOI: 10.1186/1477-7827-3-54.

References
1.
Albano C, Smitz J, Camus M, Riethmuller-Winzen H, VAN Steirteghem A, Devroey P . Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril. 1997; 67(5):917-22. DOI: 10.1016/s0015-0282(97)81407-0. View

2.
Brus L, Lambalk C, de Koning J, Helder M, Janssens R, Schoemaker J . Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles. Hum Reprod. 1997; 12(4):769-73. DOI: 10.1093/humrep/12.4.769. View

3.
Lin Y, Kahn J, Hillensjo T . Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?. Hum Reprod. 1999; 14(4):885-8. DOI: 10.1093/humrep/14.4.885. View

4.
Weiss J, Oltmanns K, Gurke E, Polack S, Eick F, Felberbaum R . Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells. Eur J Endocrinol. 2001; 144(6):677-85. DOI: 10.1530/eje.0.1440677. View

5.
Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G . Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod. 2001; 16(11):2258-62. DOI: 10.1093/humrep/16.11.2258. View